Your session is about to expire
← Back to Search
Islet Transplant Techniques for Chronic Pancreatitis (iSite Trial)
iSite Trial Summary
This trial is testing whether or not it's better to transplant islets into the omentum (a fold of the peritoneum) or leave them in the liver. They will compare islet function in patients to a group of normal volunteers.
iSite Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowiSite Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.iSite Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My liver enzymes are higher than normal, but it's not due to a benign condition like Gilbert's.I am not using steroids that could affect my blood sugar, except for certain allowed types.I haven't taken diabetes medications like insulin or metformin in the last 30 days.I am approved for a total pancreatectomy and islet autotransplantation at the University of Minnesota.I have a blood clotting disorder or need blood thinners before surgery.My diabetes is not well-controlled, with high blood sugar or A1c levels.I am currently using or plan to use medication that weakens my immune system.I am between 18 and 68 years old.
- Group 1: Intrahepatic islets alone
- Group 2: Intrahepatic and omental pouch islets
- Group 3: Normal Volunteers
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the upper cap of enrollees for this research project?
"Affirmative, the details on clinicaltrials.gov demonstrate that this medical examination is currently recruiting participants. It was initially posted August 1st 2019 and was recently updated September 16th 2022; 45 individuals are sought from a single location."
Who is the intended demographic for this clinical trial?
"This clinical trial is searching for 45 individuals aged 18 to 68 with a diagnosis of chronic pancreatitis. To be eligible, they must also have been approved and reviewed by the multi-disciplinary committee at the University of Minnesota for total pancreatectomy and IAT. The panel includes surgeons, gastroenterologists focused on pancreatic disease, pain specialists, psychologists, and endocrinologists."
Has recruitment for this investigation begun?
"According to the records on clinicaltrials.gov, this trial is presently enlisting volunteers. Initially posted on August 1st 2019 and last modified 16th of September 2022, it continues to seek participants for its study."
Is the eligibility for this research study restricted to adults over the age of twenty?
"This trial has established a minimum age of 18 and an upper limit of 68 for patient inclusion."
Share this study with friends
Copy Link
Messenger